Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 16:13:503-510.
doi: 10.2147/PGPM.S273125. eCollection 2020.

Genetic Association of Epilepsy and Anti-Epileptic Drugs Treatment in Jordanian Patients

Laith N Al-Eitan  1   2 , Islam M Al-Dalala  3 , Afrah K Elshammari  4 , Wael H Khreisat  4 , Aseel F Nimiri  4 , Adan H Alnaamneh  1 , Hanan A Aljamal  1 , Mansour A Alghamdi  5   6
Affiliations

Genetic Association of Epilepsy and Anti-Epileptic Drugs Treatment in Jordanian Patients

Laith N Al-Eitan et al. Pharmgenomics Pers Med. .

Abstract

Purpose: The aim of this study was to investigate the possible effects of single-nucleotide polymorphisms (SNPs) within SLC1A1, SLC6A1, FAM131B, GPLD1, F2, GABRG2, GABRA1, and CACNG5 genes on response to anti-epileptic drugs (AEDs) and the genetic predisposition of epilepsy in Jordanian patients.

Patients and methods: A total of 299 healthy individuals and 296 pediatric patients from the Jordanian population were recruited. Blood samples are collected, and genotyping was performed using a custom platform array analysis.

Results: The SLC1A1 rs10815018 and FAM131B rs4236482 polymorphisms found to be associated with epilepsy susceptibility. Moreover, SLC1A1 rs10815018 and GPLD1 rs1126617 polymorphisms were associated with generalized epilepsy (GE), while FAM131B rs4236482 is associated with the focal phenotype. Regarding the therapeutic response, the genetic polymorphisms of FAM131B rs4236482, GABRA1 rs2279020, and CACNG5 rs740805 are conferred poor response (resistance) to AEDs. There was no linkage of GLPD1 haplotypes to epilepsy, its subtypes, and treatment responsiveness.

Conclusion: Our findings suggested that SLC1A1, FAM131B, and GPLD1 polymorphisms increasing the risk of generating epilepsy, while FAM131B, GABRA1, and CACNG5 variants may play a role in predicting drug response in patients with epilepsy (PWE).

Keywords: Jordan; anti-epileptic drugs; focal epilepsy; generalized epilepsy; pharmacogenetics; pharmacotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Löscher W, Potschka H, Sisodiya SM, et al. Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev. 2020;72:606–638. doi:10.1124/pr.120.019539 - DOI - PMC - PubMed
    1. World Health Organization. Epilepsy: aetiology, epidemiology and prognosis. Fact sheet no. 165; 2001. Available from: http://www.who.int/news-room/fact-sheets/detail/epilepsy. Accessed July20, 2020.
    1. Kjeldsen MJ, Kyvik KO, Friis ML, et al. Genetic and environmental factors in febrile seizures: a Danish population-based twin study. Epilepsy Res. 2002;51:167–177. doi:10.1016/S0920-1211(02)00121-3 - DOI - PubMed
    1. Hedrich U, Maljevic S, Lerche H. Mechanisms of genetic epilepsies. e-Neuroforum. 2013;4:23–30.
    1. Cavalleri GL, McCormack M, Alhusaini S, et al. Pharmacogenomics and epilepsy: the road ahead. Pharmacogenomics. 2011;12:1429–1447. doi:10.2217/pgs.11.85 - DOI - PubMed